These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 25495890)
1. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer. Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. Hu FQ; Liu LN; Du YZ; Yuan H Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395 [TBL] [Abstract][Full Text] [Related]
3. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin. Hu FQ; Wu XL; Du YZ; You J; Yuan H Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293 [TBL] [Abstract][Full Text] [Related]
4. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy. Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168 [TBL] [Abstract][Full Text] [Related]
5. RGD peptide-mediated chitosan-based polymeric micelles targeting delivery for integrin-overexpressing tumor cells. Cai LL; Liu P; Li X; Huang X; Ye YQ; Chen FY; Yuan H; Hu FQ; Du YZ Int J Nanomedicine; 2011; 6():3499-508. PubMed ID: 22282676 [TBL] [Abstract][Full Text] [Related]
6. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles. Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485 [TBL] [Abstract][Full Text] [Related]
7. Brain-targeting study of stearic acid-grafted chitosan micelle drug-delivery system. Xie YT; Du YZ; Yuan H; Hu FQ Int J Nanomedicine; 2012; 7():3235-44. PubMed ID: 22802685 [TBL] [Abstract][Full Text] [Related]
8. Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery. Ye YQ; Chen FY; Wu QA; Hu FQ; Du YZ; Yuan H; Yu HY J Pharm Sci; 2009 Feb; 98(2):704-12. PubMed ID: 18563810 [TBL] [Abstract][Full Text] [Related]
9. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy. Hu FQ; Zhang YY; You J; Yuan H; Du YZ Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551 [TBL] [Abstract][Full Text] [Related]
10. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles. Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183 [TBL] [Abstract][Full Text] [Related]
11. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin. Xiong XB; Ma Z; Lai R; Lavasanifar A Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492 [TBL] [Abstract][Full Text] [Related]
12. Stearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorption. Yuan H; Lu LJ; Du YZ; Hu FQ Mol Pharm; 2011 Feb; 8(1):225-38. PubMed ID: 21138243 [TBL] [Abstract][Full Text] [Related]
13. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer. Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816 [TBL] [Abstract][Full Text] [Related]
14. Targeting delivery of tocopherol and doxorubicin grafted-chitosan polymeric micelles for cancer therapy: In vitro and in vivo evaluation. Nam JP; Lee KJ; Choi JW; Yun CO; Nah JW Colloids Surf B Biointerfaces; 2015 Sep; 133():254-62. PubMed ID: 26117805 [TBL] [Abstract][Full Text] [Related]
15. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells. Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942 [TBL] [Abstract][Full Text] [Related]
16. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684 [TBL] [Abstract][Full Text] [Related]
17. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455 [TBL] [Abstract][Full Text] [Related]
18. TNYL peptide functional chitosan-g-stearate conjugate micelles for tumor specific targeting. Chen FY; Yan JJ; Yi HX; Hu FQ; Du YZ; Yuan H; You J; Zhao MD Int J Nanomedicine; 2014; 9():4597-608. PubMed ID: 25298734 [TBL] [Abstract][Full Text] [Related]
19. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer. Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074 [TBL] [Abstract][Full Text] [Related]
20. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs. Hong G; Yuan R; Liang B; Shen J; Yang X; Shuai X Biomed Microdevices; 2008 Oct; 10(5):693-700. PubMed ID: 18350380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]